Ceftazidime or amikacin: choice of intravitreal antimicrobials in the treatment of postoperative endophthalmitis.
Doft
B H
BH
Barza
M
M
D000583:Amikacin / Q000009:adverse effects / Q000627:therapeutic use*; D000818:Animals; D002442:Ceftazidime / Q000009:adverse effects / Q000627:therapeutic use*; D004361:Drug Tolerance; D009877:Endophthalmitis / Q000188:drug therapy* / Q000382:microbiology; D015818:Eye Infections, Bacterial / Q000188:drug therapy*; D006801:Humans; D011183:Postoperative Complications / Q000188:drug therapy* / Q000382:microbiology; D011817:Rabbits; D014822:Vitreous Body
D000583:Amikacin; D002442:Ceftazidime